Caspase-3, myogenic transcription factors and cell cycle inhibitors are regulated by leukemia inhibitory factor to mediate inhibition of myogenic differentiation

Skeletal Muscle

Volumn 1, Issue 1, 2011, Pages

  Hunt, Liam C ^a,b   Upadhyay, Aradhana ^c   Jazayeri, Jalal A ^c   Tudor, Elizabeth M ^a   White, Jason D ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860118049     PISSN: None     EISSN: 20445040     Source Type: Journal    
DOI: 10.1186/2044-5040-1-17     Document Type: Article

References (37)

1. Hanzlíková V, Macková EV, Hnik P. Satellite cells of the rat soleus muscle in the process of compensatory hypertrophy combined with denervation. Cell and Tissue Research 1975, 160:411-421.
2. Murre C, McCaw PS, Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 1989, 56:777-783. 10.1016/0092-8674(89)90682-X, 2493990.
3. Wright WE, Sassoon DA, Lin VK. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 1989, 56:607. 10.1016/0092-8674(89)90583-7, 2537150.
4. Andres V, Walsh K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. Journal of Cell Biology 1996, 132:657. 10.1083/jcb.132.4.657, 2199863, 8647896.
5. Guo K, Wang J, Andres V, Smith RC, Walsh K. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Molecular and cellular biology 1995, 15:3823. 230621, 7791789.
6. Taylor MV. Muscle development: molecules of myoblast fusion. Current Biology 2000, 10:R646-R648. 10.1016/S0960-9822(00)00664-3, 10996092.
7. Wang J, Walsh K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 1996, 273:359. 10.1126/science.273.5273.359, 8662523.
8. Fernando P, Kelly JF, Balazsi K, Slack RS, Megeney LA. Caspase 3 activity is required for skeletal muscle differentiation. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:11025. 10.1073/pnas.162172899, 123204, 12177420.
9. Shaltouki A, Freer M, Mei Y, Weyman CM. Increased expression of the pro-apoptotic Bcl 2 family member PUMA is required for mitochondrial release of cytochrome C and the apoptosis associated with skeletal myoblast differentiation. Apoptosis 2007, 12:2143-2154. 10.1007/s10495-007-0135-z, 17879164.
10. Kurek JB, Nouri S, Kannourakis G, Murphy M, Austin L. Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle. Muscle & nerve 1998, 19:1291-1301.
11. Jo C, Kim H, Jo I, Choi I, Jung SC, Kim J, Kim SS, Jo SA. Leukemia inhibitory factor blocks early differentiation of skeletal muscle cells by activating ERK. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 2005, 1743:187-197.
12. Gearing DP, VandenBos T, Beckmann MP, Thut CJ, Comeau MR, Mosley B, Ziegler SF. Reconstitution of high affinity leukaemia inhibitory factor (LIF) receptors in haemopoietic cells transfected with the cloned human LIF receptor. Ciba Found Symp 1992, 167:245.
13. Spangenburg EE, Booth FW. Multiple signaling pathways mediate LIF-induced skeletal muscle satellite cell proliferation. American Journal of Physiology-Cell Physiology 2002, 283:C204.
14. Hunt LC, Tudor EM, White JD. Leukemia inhibitory factor-dependent increase in myoblast cell number is associated with phosphotidylinositol 3-kinase-mediated inhibition of apoptosis and not mitosis. Experimental Cell Research 2009,
15. Kurek JB, Bower JJ, Romanella M, Koentgen F, Murphy M, Austin L. The role of leukemia inhibitory factor in skeletal muscle regeneration. Muscle & nerve 1998, 20:815-822.
16. Zalin R. Creatine kinase activity in cultures of differentiating myoblasts. J Biol Chem 1967, 242:204-209.
17. Rahm M, Jin P, Sümegi J, Sejersen T. Elevated c-fos expression inhibits differentiation of L6 rat myoblasts. Journal of cellular physiology 1989, 139:237-244. 10.1002/jcp.1041390204, 2469685.
18. Li L, Chambard JC, Karin M, Olson EN. Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression. Genes & development 1992, 6:676.
19. Austin L, Burgess AW. Stimulation of myoblast proliferation in culture by leukaemia inhibitory factor and other cytokines. Journal of the neurological sciences 1991, 101:193-197. 10.1016/0022-510X(91)90045-9, 1903437.
20. Alter J, Rozentzweig D, Bengal E. Inhibition of myoblast differentiation by TNF is mediated by c-Jun N-terminal kinase 1 and Leukemia inhibitory factor. Journal of Biological Chemistry 2008,
21. Fairlie WD, Uboldi AD, McCoubrie JE, Wang CC, Lee EF, Yao S, De Souza DP, Mifsud S, Metcalf D, Nicola NA. Affinity maturation of leukemia inhibitory factor and conversion to potent antagonists of signaling. Journal of Biological Chemistry 2004, 279:2125. 10.1074/jbc.M310103200, 14585833.
22. Wang X, Wu H, Zhang Z, Liu S, Yang J, Chen X, Fan M. Effects of Interleukin-6, Leukemia Inhibitory Factor, and Ciliary Neurotrophic Factor on the Proliferation and Differentiation of Adult Human Myoblasts. Cell Mol Neurobiol 2008, 28:113-124. 10.1007/s10571-007-9247-9, 18240017.
23. Vakakis N, Bower J, Austin L. In vitro myoblast to myotube transformations in the presence of leukemia inhibitory factor. Neurochemistry international 1995, 27:329-335. 10.1016/0197-0186(95)00014-Y, 8845733.
24. Marquant-Le Guienne B, Humblot P, Guillon N, Thibier M. Murine LIF improves the development of IVF cultured bovine morulae. J Reprod Fertil Abstr 1993, 12:61.
25. Piedrahita JA, Weaks R, Petrescu A, Shrode TW, Derr JN, Womack JE. Genetic characterization of the bovine leukaemia inhibitory factor (LIF) gene: isolation and sequencing, chromosome assignment and microsatellite analysis. Animal genetics 1997, 28:14-20. 10.1111/j.1365-2052.1997.00054.x, 9124702.
26. Broholm C, Pedersen BK. Leukaemia inhibitory factor--an exercise-induced myokine. Exercise immunology review 2010, 16:77.
27. Jiang BH, Zheng JZ, Vogt PK. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:14179. 10.1073/pnas.95.24.14179, 24347, 9826674.
28. Allan LA, Morrice N, Brady S, Magee G, Pathak S, Clarke PR. Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nature cell biology 2003, 5:647-654. 10.1038/ncb1005, 12792650.
29. Freer-Prokop M, O'Flaherty J, Ross JA, Weyman CM. Non-canonical role for the TRAIL receptor DR5/FADD/caspase pathway in the regulation of MyoD expression and skeletal myoblast differentiation. Differentiation 2009, 78:205-212. 10.1016/j.diff.2009.05.002, 2784740, 19523746.
30. Larsen BD, Rampalli S, Burns LE, Brunette S, Dilworth FJ, Megeney LA. Caspase 3/caspase-activated DNase promote cell differentiation by inducing DNA strand breaks. Proceedings of the National Academy of Sciences 2010, 107:4230.
31. Sonnet C, Lafuste P, Arnold L, Brigitte M, Poron F, Authier F, Chretien F, Gherardi RK, Chazaud B. Human macrophages rescue myoblasts and myotubes from apoptosis through a set of adhesion molecular systems. Journal of cell science 2006, 119:2497. 10.1242/jcs.02988, 16720640.
32. Kami K, Senba E. Localization of leukemia inhibitory factor and interleukin-6 messenger ribonucleic acids in regenerating rat skeletal muscle. Muscle & nerve 1998, 21:819-822.
33. Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 1992, 255:1434-1437. 10.1126/science.1542794, 1542794.
34. Zhang Y, Willson T, Metcalf D, Cary D, Hilton DJ, Clark R, Nicola NA. The box-1 region of the leukemia inhibitory factor receptor alpha-chain cytoplasmic domain is sufficient for hemopoietic cell proliferation and differentiation. J Biol Chem 1998, 273:34370-34383. 10.1074/jbc.273.51.34370, 9852103.
35. Jazayeri JA, De Weerd N, Raye W, Kivivuori S, Zabihi E, Carroll GJ. In vitro evaluation of leukemia inhibitory factor receptor antagonists as candidate therapeutics for inflammatory arthritis. J Interferon Cytokine Res 2007, 27:281-289. 10.1089/jir.2006.0138, 17477816.
36. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 2001, 29:e45. 10.1093/nar/29.9.e45, 55695, 11328886.
37. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnology letters 2004, 26:509-515. 10.1023/B:BILE.0000019559.84305.47, 15127793.